Business
Solésence Reports First Quarter 2026 Financial Results
Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. “In March, we introduced Transform and Transcend to our investor community, the strategic initiative
About this update from Solesence, Inc.
[{"type":"image","alt":"Solésence, Inc.","displaySize":"","headline":null,"caption":"Solésence, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":298,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/7f0b5f2aae8717562a59d4f306203102"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Z6YhWrEl_VXGj_Xnl_oHbA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMw--/https://media.zenfs.com/en/globenewswire.com/7f0b5f2aae8717562a59d4f306203102","width":298,"height":300},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Z6YhWrEl_VXGj_Xnl_oHbA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMw--/https://media.zenfs.com/en/globenewswire.com/7f0b5f2aae8717562a59d4f306203102","width":298,"height":300}},"lazy":false},{"type":"text","content":"Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization","length":138,"tagName":"p"},{"type":"text","content":"ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026.","length":259,"tagName":"p"},{"type":"text","content":"“In March, we introduced Transform and Transcend to our investor community, the strategic initiative that we began at the end of 2025,” commented Kevin Cureton, President and Chief Executive Officer. “Our first quarter results reflect our disciplined execution on this initiative, particularly on our first and foundational pillar, operational excellence. Combined with steady early progress in our efforts to further leverage our intellectual property, expand our addressable market, and evolve our service model to capture greater share of the value chain, Solésence is well positioned to drive long-term, sustainable profitability and growth.”","length":646,"tagName":"p"},{"type":"text","content":"Recent Highlights and Accomplishments","length":37,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Improved gross margin through disciplined execution of first pillar of Transform & Transcend Initiative: Operational Excellence.","length":132,"tagName":"p"}]},{"val":[{"type":"text","content":"Expanded OTC claims with commercialization of new platform technologies: WHSPR™ and Chromalüm...